Zobrazeno 1 - 10
of 13 254
pro vyhledávání: ''
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Aging associated with progressive declines in physical function is well-known; however, little is known about the trajectories of physical function before and after breast cancer diagnosis. The current study examined the trajectories in obje
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Elotuzumab plus pomalidomide/dexamethasone (E-Pd) demonstrated efficacy and safety in relapsed and refractory multiple myeloma (RRMM). The clinical pharmacology of elotuzumab [± lenalidomide/dexamethasone (Ld)] was characterized previously.
Publikováno v:
Breast Cancer Research and Treatment
Purpose Breast cancer survivors take vitamins and supplements to bolster their general health and to decrease the risk of cancer recurrence. Healthcare providers are frequently unaware of their patients non-prescription supplement use. The aim of thi
Publikováno v:
Breast Cancer Research and Treatment. 191:477-480
The 21-gene Oncotype DX Breast Recurrence Score® test, (Genomic Health, Redwood City CA) has not been formally evaluated in an older cohort with estrogen receptor (ER)-positive breast cancer (BC) in term of physicians’ treatment decisions. We dete
Autor:
Jeanne S. Mandelblatt, Martine Extermann, Tim A. Ahles, Judith E. Carroll, Kathleen Van Dyk, Harvey J. Cohen, Wanting Zhai, Deena Graham, Brent J. Small, Marie Lange, Florence Joly, James C. Root, Brenna C. McDonald, Heather S.L. Jim, Xingtao Zhou, Andrew J. Saykin, Jaeil Ahn, Natacha Heutte, Sunita K. Patel
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Older cancer patients are susceptible to long-term effects of chemotherapy, including cancer-related cognitive decline and impairments to quality of life. Taxane-based chemotherapies are associated with physical declines among older women an
Autor:
Harrynauth Persaud, Jeanetta Yuan
Publikováno v:
Cancer Causes & Control. 33:241-248
The objective of this study was to explore prostate cancer screening behaviors among Indo-Guyanese men. This qualitative study was conducted in the surrounding neighborhood of Queens, New York during 2018 and 2019. In-depth, one-on-one interviews wer
Autor:
Georgia Karpathiou, Esther Guerra Fernandez, Andres A. Roma, Simona Stolnicu, Graziele Bovolim, Anna Pesci, Robert A. Soslow, Louise De Brot, Esther Oliva, Lien Hoang, Pavel Dundr, Ana Félix, Glauco Baiocchi, Maria José Brito, Antonio Ieni, Kay J. Park, Sofia Lerias, Takako Kyiokawa, Nadeem R. Abu-Rustum, Carlos Parra-Herran, Noorah Almadani
Publikováno v:
J Cancer Res Clin Oncol
PURPOSE: The 2018 International Federation of Gynecology and Obstetrics (FIGO) update on cervical cancer staging eliminated horizontal tumor extent (HZTE) as a staging parameter in stage IA (microscopic) disease. We aimed to determine whether HZTE co
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:565-575
Purpose: NRAS plays a pivotal role in progression of various kinds of somatic malignancies; however, the correlation between NRAS and lung adenocarcinoma is less known. We aim to analyze the prognostic value of NRAS expression in lung adenocarcinoma,
Autor:
Gary Middleton, Alex G. Richter, Akshay J Patel, Ti-Myen Tan, Jonathan M. Blackburn, Babu Naidu
Publikováno v:
British Journal of Cancer
Background Lung cancer is the leading cause of cancer-related death worldwide. Surgical resection remains the definitive curative treatment for early-stage disease offering an overall 5-year survival rate of 62%. Despite careful case selection, a sig
Autor:
Akihito Tsuji, Dai Manaka, Masato Kataoka, Masashi Fujii, Masahiro Takeuchi, Takanori Watanabe, Masato Nakamura, Wataru Ichikawa, Hiroshi Matsuoka
Publikováno v:
Targeted Oncology. 16:753-760
Regorafenib and trifluridine/tipiracil are standard third-line chemotherapies for colorectal cancer patients, but their efficacy is limited. Anti-epidermal growth factor receptor antibody rechallenge has been reported to be promising for patients who